In the previous communication (1) the principles of equilibrium techniques in competitive binding or saturation assays were reviewed.
In the present paper we wish to deal with the principles of another form of competitive binding, for which we have suggested the term "sequential saturation" (2) . We shall contrast this technique with those of equilibrium assays and examine its advantages as well as pitfalls, with some typical, practical applications in the clinical chemistry laboratory in mind.
It appears that the technique of sequential saturation was first proposed by Hales and Randle (3) in 1963 as an alternative modification of their insulin assay, in order to increase sensitivity.
Since then this technique has been applied by a number of workers under various terms-"non-equilibrium," "delayed addition,"
"two-step analysis," etc.-which distinguish it from equilibrium techniques. However, the principle has not received the intense theoretical and statistical examination to which the equilibrium technique has been subjected. Failure to appreciate the basic differences between sequential and equilibrium analysis has led some investigators (4) to apply the sequential saturation technique while using the mathematical concepts of equilibrium analysis. Recently Rodbard et al. (5) have presented a mathematical analysis of the kinetics of the binding reactions that occur with "delayed addition"
and demonstrated the potential enhancement of sensitivity inherent in this principle.
By examining the prerequisites necessary for the successful application of sequential saturation, we hope to clarify some of the confusion that occasionally appears to exist in the understanding of this analytical technique.
Theoretical Considerations
As a form of competitive binding assay, sequential saturation requires the same four components as equilibrium analysis, namely (a) the unlabeled hg- P's, the labeled ligand.
[P"J, the molar concentration of the free, labeled ligand. PQ, the complex between unlabeled ligand and binder. [PQ] , the molar concentration of the bound, unlabeled ligand. PQ, the complex between labeled ligand and binder.
[P 'Q] , the molar concentration of the bound, labeled ligand.
Q, the binder (specific binding agent, antibody, binding protein, tissue receptor protein, etc.).
[Q], the molar concentration of the free (unfilled) binding sites of the binder.
q, the total molar concentration of the binding sites (free plus occupied).
R, the ratio of bound to free ligand. PGA, pteroylglutamic acid. MTHFA, methyltetrahydrofolate. two techniques is a simple methodological one, i.e.,
the order of addition of reactants.
Theoretically, in the equilibrium method, P must first be mixed with a known and constant amount of P. The binder Q is then added, and the mixture is incubated to allow an equilibrium state to be reached between P, P, and Q, resulting in the formation of the complexes PQ and * Q. It should be stated, however, that in using equilibrium methods in practice, the order of addition of P, P, and Q can be different when (a) the state of total dissociation of the reactants desirable for the incipiency of the equilibrium reaction can be re-established in a premixed system of reactants by such means as heating (6) or changing the pH (7) ; (b) when the reaction velocity between ligands and binder is so slow that no appreciable amounts of the complexes PQ and P*Q are formed during the pipetting steps; or (c) when sufficient incubation time is allowed to reach equilibrium through back-dissociation and re-association of the preformed PQ and P*Q that might have been initially present in nonequilibrium proportions in the reaction mixture (5) . Since the combined quantities of P and P* must be greater than the binding capacity of Q, only proportional amounts of P and P* become bound. Thus, only a fraction of P is participating in complex formation, the size of this fraction decreasing as the total of P increases.
In the sequential saturation method, P is first mixed with an amount of Q whose binding capacity exceeds the total amount of P added, so that essentially all of P can become bound during this incubation period. In the second step, P* is then added to react with the binding sites that have remained unoccupied by P during the first reaction step. In some greatly oversimplified fashion, for instructional purposes, these two sequential reactions can be thought of as irreversible and, accordingly, formulated by [ 
[Q,]= [Q0]-[PQ]
In the equilibrium method P* competes with P during their simultaneous incubation for all of the available binding sites of Q, while in sequential saturation such competition is essentially eliminated. Whatever competition occurs is confined to the second incubation step. When starting with the same initial concentration of reactants, less of P will become bound in equilibrium than in sequential saturation analysis. At zero dose of P, the amount of P5Q formed in both techniques will, of course, be identical, but the same finite dose of P will bring about a greater decrease of P*Q in sequential saturation than in equilibrium analysis, resulting in steeper dose-response curves. If the precision of both assay forms is the same, increased sensitivity will be observed.
The above considerations bear important implications for the type of dose-response curves to be anticipated in sequential saturation.
In reaction 1,
where Q is in excess, P is the limiting factor, and if essentially all of the P reacts, the resulting [PQ] for practical purposes will be equal to the initial [P] . In reaction 2, where P* is in excess, and all of the remaining binding sites become saturated by P", [PQ] will be equal to [Qi] . Therefore, in equation 3 we can substitute P*Q for Qi, and P for PQ, and write: (4) In words, this equation says that the quantity of the complex between the labeled ligand and the binder formed in reaction 2 (the quantity sought in the measurement)
is the difference between the molar concentration of the binder and that of the unlabeled higand. Thus, the quantity of P*Q should be inversely but linearly related to that of P and dose-response curves should be linear graphs of plots of counts per minute vs. the dose of the unlabeled ligand. This, however, is true only, as we will show later, for the special case in which the concentrations of reactants are high.
Up to this point we have presented the process of complex formation as though the association between the higand and the binder were irreversible. Such a concept, of course, is not entirely correct, since these binding processes are known to be reversible at varying rates, governed by the rules of dissociation reactions. It is for this reason that sequential saturation is not applicable to all competitive-binding assays, the limiting factor being the extent of dissociation of the bound, unlabeled ligand that oc- Stated in another way, in sequential saturation it is desirable that the complex PQ formed during the first incubation step remain essentially undissociated during reaction 2. If this condition is not fulfilled, P may replace large amounts of P in the initially formed complexes of PQ. Significant advantages of sequential saturation will be seen mostly in those instances where the binding between P and is sufficiently firm so that the extent of dissociation of PQ during the second incubation step can be disregarded.
Proper understanding of the sequential saturation principle comes through the realization that the association reactions shown in formulas 1 and 2 are, in fact, reversible equilibrium reactions that are shifted in the direction of complex formation. It then follows that assay conditions should be chosen in such a way that association is maximized and dissociation kept to a minimum.
Certain predictions of the behavior of the binding system in sequential saturation are possible, based on calculation from the equilibrium constant K, provided that the conditions under which K is determined are the same as the conditions of the assay in regard to pH, ionic strength, temperature, etc. With K in mind, the effectiveness of the sequential saturation principle in a given test system will depend on the molar concentrations of the reactants P, P, and
In a sequential saturation assay, the experimental protocol is as follows:
Step I: Incubation of unlabeled ligand with binder until equilibrium is reached.
Step II: Subsequent addition of labeled ligand and incubation until a sufficiently close approach to equilibrium is reached between the labeled higand and the binding sites that remain free after step I.
Step III: Separation of bound from free higand. It is assumed that step Ill terminates step II instantly and that the separation of bound and free higand is perfect; accordingly, we shall not consider the separation step any further.
The equilibrium reaction of step I is given by the formula
and the ratio R, (B/F, the ratio of bound to free unlabeled higand) is obtained from (8) 
The incubation time in step I is determined by the time t needed to allow equilibrium (full binding) to be reached between the reactants. Theoretically, perfect equilibrium in these types of reactions is reached when t is infinity. A finite value for t must be chosen. Since the product of interest in the reaction of step I is [PQ] , an incubation time is selected to allow sufficient formation of the complex PQ so that its value becomes experimentally indistinguishable from that reached at perfect equilibrium.
The formation of PQ with respect to time is given by the differential equation (5) .
The calculation of t for a given assay, however, is not often possible, because the values for k1 and k2 are usually not known. The incubation times, in practice, are derived from association studies under conditions of ionic strength, pH, temperature, protein content, etc., identical to those of the intended assay. It is particularly important to keep in mind that incubation times also depend on reactant concentrations.
The higher the concentrations of p and (or) q, the less time is needed to reach a given concentration of bound ligand. Indeed, equilibrium in a given assay is reached faster in the test tubes with the high doses of p than in those with the lower doses. To devise a workable assay, however, in practice, uniform incubation times are chosen for all dose levels of p. Because q is fixed in any one assay, the incubation period is determined by the time needed to establish equilibrium between ligand and binder with the lowest concentration of total ligand, i.e., p + p*, In equilibrium techniques, this lowest dose is given by the conditions when p = 0, and only p' and q are present. In other words, the incubation time to be used is that needed for equilibrium to be attained between the binder and the labeled ligand alone. In contrast to this, in sequential saturation where no p' is present during the first incubation step, the dose of the higand for which the incubation time should be determined must be chosen in some other way, necessarily as that dose of p that requires the longest incubation time for maximal binding.
For practical purposes, however, it should be emphasized that the incubation times needed to reach equilibrium do not change drastically within a binding system when the concentration of q is kept constant and that of p is set equal to or smaller than q. Large differences are observed only when the concentrations of p exceed that of q, or when the concentrations of both p and q are varied. Thus, the time requirements for incubation step I should be determined from association studies where the binder is used in the same concentration as in the intended assay and where the ligand concentration is chosen to be equal to or less than that of the binder.
The incubation time of step II, beginning with the (6) addition of the labeled ligand, is determined by the time needed to reach sufficient binding between p* and [Qi] with the lowest dose of p. which, of course, may be zero. Thus, the second incubation period is determined by the concentrations of p" and EQo], a condition identical to that in the equilibrium technique.
The kinetics of the second incubation step in sequential saturation represent an interesting and, on closer examination, a rather complex phenomenon for which a mathematical solution leads to a series of differential equations that are beyond the intended purpose of this communication.
A computer-based mathematical analysis of these kinetics for the spe-cial case when p* 4/K and q = 3/K has been published by Rodbard et al. (5) .
At the end of step I, an equilibrium has been reached according to formula 5. The addition of the labeled higand at the beginning of step II leads to a sudden increase of the total concentration of free hgand, resulting in a disturbance of the equilibrium of step I, and, accordingly, additional complex formation. This process will continue until a new equilibrium has been reached, for which total bound ligand is given by R = B/F and R is defined by
The distribution of PQ and P*Q, however, will not be directly proportional to the ratio of p and p" present in the incubation mixture.
In equilibrium techniques, the ratio p*/(p* + p) ("isotope dilution") (1) 
is identical with the ratio [P*Q]/([P*Q] +
[PQ]) at any point in time and for any given dose of p. This is not so in sequential saturation.
When the labeled higand is added at the beginning of step II, it will undergo "dilution"
only by the unlabeled higand that has remained free at the end of step I. This effective "isotope dilution" is now given by the ratio p*/p* + [P] . During the incubation step II, simultaneous with the new formation of complexes of P*Q and PQ, there will also be dissociation of the complex PQ formed in incubation step I, a process governed by the dissociation constant k2. The bound molecules of unlabeled ligand liberated through this spontaneous dissociation will be exchanged for free ligands of P and P5 in a ratio again determined by the isotope dilution.
One also has to take into account that this dissociation process will lead to a dilution, progressive with time, of the free pool of [P] + [P*] by the unlabeled ligand P from the complex PQ. Thus, the total amount of the complex P*Q formed derives from two processes: (a) additional association of higands and binder, representing the differences between the equilibria of incubation steps I and II, and (b) the exchange of P for P in the complex PQ from incubation step I. If the incubation time of step II is prolonged beyond the established time t (necessary to reach near-equilibrium with p" and q alone), the total bound fraction of higand, i.e., the sum of [PQ] + [P*Q] will not change; however, the free * will progressively exchange for P bound in PQ through continuing dissociation and re-association until the ratio of [P*Q]/ [PQ] is the same as [P*]/ [P] or that of p5/p, a condition identical with that of the equilibrium technique.
The potential increase in sensitivity by sequential saturation derives from the fact that the reaction at the end of incubation step 11 is terminated before this full exchange of P for P occurs. Less P*Q is allowed to form in the presence of the same dose of P in sequential saturation than would have been formed in equilibrium analysis.
Because the reaction is terminated before full equilibrium has been reached in regard to the formation of P*Q, variations in the incubation time of step II between the test tubes within any one run may lead to a markedly increased experimental error. As pointed out earlier, the incubation times needed to establish equilibrium are inversely related to the concentration of reactants; i.e., the higher the concentrations, the shorter the incubation times. In an example given by Potts et al. (9) , using a radioimmunoassay for parathormone, the incubation time could be shortened from five days to 2 h by choosing higher concentrations.
An example of extremely high concentrations of reactants leading to very short incubation times is found with the enzyme immunoassay (10, 11) (EMIT System2), where the few seconds elapsing between the sequential pipetting steps are sufficient for maximal complex formation.
On the other hand, the dissociation of the complex PQ, visualized as a first-order reaction, is concentration independent;
this results in the phenomenon that the shorter the time used in incubation step II, the smaller the extent of dissociation of the complex PQ will be. With higher concentrations of reactants, only such short incubation times may be needed that the dissociation of PQ becomes negligible. It is under such conditions that the binding system, for practical purposes, behaves as if the reaction P + Q -PQ were irreversible.
An interesting and important advantage of such binding systems is the facility with which one can overcome the difficulties encountered when the unlabeled and labeled ligands are chemically so different that they may possess greatly differing affinities for the binder, a situation in which equilibrium techniques generally are not applicable.
Let us consider the example of the unlabeled hgand having an affinity for the binder that is lower than that of the labeled higand. For instance, this is the case in the folate assay as described by Rothenberg et al. (12) , using a milk binder, where the unlabeled higand is methyltetrahydrofolate and the labeled higand is fohic acid. The unlabeled ligand is bound in step I to the binder. The labeled higand added in step II, because of its higher affinity, requires a considerably shorter incubation time than the first step. During this short period of time, there will be only negligible dissociation of PQ, the effect being as if P has been bound irreversibly in step I. Because of the sequencing of the addition of the two higands, the labeled higand with the higher affinity does not compete preferentially for the binding sites on the binder.
In the following we should like to demonstrate the application of the sequential saturation principle and its consequences to binding systems (a) in which the concentration of reactants in terms of 1/K is high, (b) in which it is how, and (c) in which the affinities of 'Syva Co., 3181 Porter Drive, Palo Alto, Calif. which is a measure of the fraction of digoxin bound to its antibody. The concentration of the reactants was chosen to approximate p* = 20/K, and q = 40/K, based on the estimated affinity constant K for this particular system (1) . The result is a binding curve as a function of time shown in Figure 1 . As is evident, the binding reaction is essentially completed at 4 mm. Since it was found that the affinity of the labeled and unlabeled digoxins was the same for this antibody, the time needed for completion of complex formation obviously would determine the length of both incubation steps of sequential saturation.
As it was also important to gain some insight into the rate of displacement of the unlabeled digoxin from the complex formed in the first incubation step by the labeled digoxin during the second incubation step, the dissociation reaction of the digoxin-antibody complex was studied. This was accomplished by two different techniques.
The first is based on the addition of a large excess of unlabeled ligand as used by Farr (13) A large excess of unlabeled digoxin was then added, exceeding the original binding capacity of the antibody at least 1000-fold. After increasing times of incubation, charcoal was then added to adsorb the free digoxin, and after centrifugation the radioactivity of the supernatant fluid was determined.
In this system more than 95% of the dose of [3H]digoxin is initially bound. As spontaneous dissociations occur during the second incubation period with the unlabeled digoxin, the E3H]digoxin molecules in the complex will be progressively replaced almost exclusively by the unlabeled digoxin, since the latter is present in large excess. The chance that a [3Hjdigoxin molecule, after having dissociated from the complex, would again become bound under these conditions was 1 in 1000. The exchange of unlabeled for labeled digoxin in the complex is time-dependent and proceeds according to the speed of dissociation. Thus, the decrease in the radioactivity of the supernate with time is a measure of the dissociation velocity.
The second technique is based on charcoal adsorption. Aliquots of antibody were first reacted with [3H]digoxin until equilibrium was reached. Charcoal was then added and the test tubes were slowly rotated to ensure continuous suspension of the charcoal. At increasing time intervals the test tubes were centrifuged, and the radioactivity of the supernatant fluid was determined.
The role of the charcoal in this system is similar to that of dialysis. Precluding the possibility of actively "stripping" digoxin molecules from the complexes, the charcoal will be able to adsorb only those [3H]digoxin molecules that have become available through spontaneous dissociation events.
The resulting dissociation curves are shown in Figure digoxmn to its antibody were essentially irreversible.
In view of the above information, it can be anticipated that essentially the entire dose of the unlabeled digoxin would become bound and remain bound during addition of labeled digoxin and charcoal treatment.
Therefore, the simple formulation for the quantity of [Pd'Q] of formula 4 would apply, and a dose-response curve with an essentially linear component over the major portion of the graph is anticipated. This is borne out by Figure 3 , where dose-response curves obtained by the equilibrium and sequential saturation methods are compared. The sequential saturation curve is considerably steeper, indicating greater sensitivity. However, it is also of import to note that the useful range of this curve is more limited than that of equilibrium.
The curvature seen with the higher doses of digoxin is a reflection of the fact that the percentage of digoxin that is bound decreases with increasing dose, a relationship demonstrated in Figure 4 , where the percentages are shown for each digoxin dose. Varying the concentration of antibody leads to a family of dose-response curves in which the linear components are parallel to each other ( Figure 5 ). with full binding being reached in 12 h at 4 #{176}C and in 3 h at 22 #{176}C. It is also apparent that the equilibrium is shifted farther in the direction of complex formation at 4#{176}C than at 22 #{176}C. Dissociation was studied by first allowing the formation of the complex between r25I]insulin and double antibody.
This was followed by the addition of a 500-fold excess of unlabeled insulin, analogous to the principle described above for the study of digoxin dissociation.
One series of test tubes was kept at 22 #{176}C, the other at 4 #{176}C. The incubation mixture was then filtered at various time intervals, and the radioactivity determined as a measure of the labeled complex that had not dissociated.
The results are shown in Figure 7 . Dissociation is considerably faster at the higher temperature, with 50% dissociation reached in 9.5 h at 22 #{176}C and in about 30 h at 4 #{176}C. Both dissociation curves also indicate a more rapid component of dissociation during the first few hours of incubation than would be predicted when the curves are calculated on the basis of a simple first-order reaction. This is due to the fact that antisera are almost always mixtures of antibodies of differing avidity for their antigens.
The complexes between insulin and the antibody molecules of lower avidity will dissociate faster than others, a phenomenon that causes the initial steep component of the curves. In such systems, because of the long incubation times relative to the dissociation rate, considerable dissociation would be expected to occur during the second incubation step of a sequential saturation reaction, allowing more of the complex P4Q to form than if the complex PQ remained undissociated. In other words, during the second incubation step, equilibrium conditions are approached.
The consequence for dose-response curves will be that the sequential saturation curve will show little increase in sensitivity over that of equilibrium. This is well borne out by Figure 8 , where dose-response curves run at 22 #{176}C by the equilibrium method as well as the sequential saturation method are compared. The two curves are quite similar, the sequential saturation curve scarcely exhibiting any increase in sensitivity.
We should also like to emphasize that the sequential saturation technique, when used under the above conditions, may be afflicted with rather poor preci- sion, obviating whatever moderate gains in sensitivity may have been anticipated from steepening of the dose-response curve. This is due to the fact that small differences in the handling and conditions of the test tubes within one run may lead to considerable differences in the dissociation of the complex PQ during the second incubation step, allowing varying amounts of P to become bound. Indeed, the poor precision obtained with some commercial kits for insulin based on the Hales and Randle technique is probably due to this problem. These differences in precision of dose-response curves by equilibrium and sequential saturation techniques are shown in Figure  8 . are complicated by the unavailability of a commercial supply of labeled MTHFA of sufficient stability and specific activity. The difficulty was effectively overcome by Rothenberg et a!. (12) , who substituted labeled pteroylglutamic acid ([3H]PGA) for MTHFA as the labeled ligand. The folate binding protein of cow's milk as used in their assay possesses significantly greater affinity for PGA than for MTHFA. The rationale for the advantageous application of sequential saturation under these circumstances has been outlined above. We have studied the association and dissociation reactions of these two folate forms with the binding protein that we isolated from cow's milk according to the procedure given by Ford et al. (14) .
The reactions with PGA were carried out by using the labeled and unlabeled forms, analogous to the techniques as outlined for digoxin and insulin. The results are shown in Figures 9 and 10 . The binding reaction was complete within 3 mm at 22 #{176}C and within 20 mm at 4 #{176}C. Dissociation was an extremely slow process; after 24 h, only 18% of the complex had dissociated at 4 #{176}C and only 23% at 22 #{176}C.
Inasmuch as labeled MTHFA of sufficient specific activity was not available, association and dissociation of the MTHFA-milk binder complex was studied by using [3HJPGA in the following ways:
Folate binder was incubated with MTHFA for increasing periods of time at the end of which [3H]PGA was added and incubated for 3 mm at 22 #{176}C and 20 mm at 4 #{176}C. The reaction was terminated by adding charcoal. The progress of the association reaction was reflected by a decrease in the bound radioactivity rather than by an increase as in the previously described association studies. The re- The more rapid dissociation in the earlier portion of the curves Indicates that the binder may consist of more than one component with differing k2 values suits are shown in Figure 11 . The binding process at 22 #{176}C was completed within 20 mm and at 4 #{176}C within 60 mm. Figure 12 . The progress of the dissociation reaction in this case is reflected by the increasing bound radioactivity.
After 24 h, 25% of the MTHFA complex had dissociated at 4 #{176}C, 62% at 22 #{176}C. A comparison between the PGA and the MTHFA association and dissociation studies clearly reflects the greater affinity of PGA for the milk foiate binder.
Of importance for the assay protocol involving with the intent to increase sensitivity. Such sensitivity gains, however, are realized best with systems in which the concentrations of reactants in terms of 1/K are high. When the concentrations are low, such long incubation times relative to the dissociation velocities are required that quasi-equilibrium conditions are approached through redissociation of the complex PQ formed initially in the first incubation step. It is further of interest to note that the detection limit will improve little, because the slope of the equilibrium dose-response curve at the lower doses of P is the steepest, and approaches that of sequential saturation (Figures 3 and 8) .
II. When the concentrations of reactants are high (q 50/K or greater), sequential saturation will produce nearly linear dose-response curves over the major "usable" portion of the curve, thereby eliminating the need for mathematical manipulations (15) to linearize the conventional equilibrium curves, such as the logit transformation.
In fact, it should be emphasized that the traditionally established means of curve linearization of equilibrium techniques do not apply in sequential saturation.
ifi. Because the labeled ligand does not compete simultaneously with the unlabeled ligand for the binding sites on the binder, it is possible to relax the requirements for precision normally re4uired for the addition of the label. Under conditions of high reactant concentrations, the binder will be nearly fully saturated by the end of incubation step II. Therefore, variations in the excess of labeled ligand will not influence appreciably the amount of P*Q formed. Indeed, the excess [P*] that remains free at the end of incubation step II increases with increasing doses of even if precisely identical quantities of p4 were used. If the labeled ligand does not contain a high nonbindable and nonadsorbable "blank" radioactive fraction, it is possible to run sequential saturation assays under such conditions by adding only approximate amounts of the label that are in excess of the binding capacity of the binder. In the digoxin assay we have varied the amount of label as much as threefold in replicate test tubes and obtained amounts of P'Q indistinguishable from each other. Accordingly, we have eliminated in our digoxin assay the volumetric pipetting of [3H]digoxin and are using simple dropwise addition instead. In fact, the calibration curves shown in Figures 3, 4 , and 5 have been produced by this technique.
IV. In equilibrium techniques the unlabeled and labeled ligands should be mixed first before they are reacted with the binder. This is especially important when the association reactions take place within minutes or seconds. This requires that aliquots of binder are added to the ligand mixtures or vice versa. Because the first step in sequential saturation involves the mixing of unlabeled ligand and the binder, it is possible to pre-pipet the binder in the final dilutions and prepare working aliquots for storage of a few weeks' or months' supply in the frozen state.
V. Perhaps the most important single advantage of the sequential saturation method is its potential to make possible the use of unlabeled and labeled ligands of differing affinities for the binder. The rationale of this principle has been discussed in detail above. It should be emphasized, however, that also in this case the concentration of Q in terms of 1/K must be high, because when concentrations are low the required time of incubation with the labeled hgand increases in relation to the dissociation velocity to such an extent that the redissociation of this complex will be of an undesirable magnitude.
The Disadvantages of Sequential Saturation
I. Although the number of pipettings is the same as in equilibrium techniques, two incubation periods are required that necessitate attention to timing and rehandling of the test tubes.
II. The timing of the length of the second incubation step must be exact for all test tubes, otherwise the extent of redissociation of PQ will vary from one test tube to the other. The timing of the first incubation step is, of course, not as critical, if sufficient equilibrium is reached between the unlabeled higand and the binder.
ifi. Sequential saturation results in calibration graphs of limited dose range because of the linear dose-response over the major portion of the curve. Where wide dose ranges are to be covered, equilibrium techniques should be chosen, because the latter produces dose-response curves of progressively decreasing slope with the highest sensitivity at the lowest doses.
IV. When concentrations of reactants are low, minor differences in the conditions in handling and timing between test tubes may cause significant differences in redissociation, allowing differing amounts of P*Q to form. It is the quantity of this complex that is measured in the assay, so poor precision may result (Figure 8) .
We hope that with the above discussion we have sufficiently outlined the rationale of the sequential saturation technique and its differentiation from equilibrium methods to be of assistance to those contemplating the selection of competitive binding assays and optimization of the methodologies for application in the clinical chemistry laboratory.
